Shares of the drugmaker
AbbVie
fell as much as 12.2% during intraday trading on Wednesday, closing down 7.1%, after the U.S. Food and Drug Administration said that it had determined that use of… [+4603 chars]
AbbVie Stock Dropped After FDA Warning. Analysts Say Selloff Is Overblown. – Barrons